<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01062893</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00009631</org_study_id>
    <nct_id>NCT01062893</nct_id>
  </id_info>
  <brief_title>Combined Spinal/Epidural (CSE) Saline Duration/Spread</brief_title>
  <official_title>Effect of Epidural Saline on Duration and Spread of Subsequent Spinal Analgesia/Anesthesia Using a CSE Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An attempt is being made to see if by injecting a set volume of sterile saline into the
      epidural space during the treatment of labor pain with a combined spinal/epidural (CSE)
      increases the amount of pain relief obtained and makes the labor analgesia lasts longer.
      Subjects are in the study from the time their CSE is placed until they request additional
      pain medication from the spinal dose of numbing medicine wearing off.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    lack of subjects and manpower issues
  </why_stopped>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Highest Sensory Blockade Level to Pinprick and to Cold</measure>
    <time_frame>up to 20 minutes</time_frame>
    <description>Onset of analgesia to recession of analgesia. Highest spread of analgesia (highest sensory level) to cold temp and pinprick, with level defined from T1 to L5, where T1 is highest =level 17 and L5 is lowest =Level 1)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of Analgesia (Time to Request Additional Analgesia)</measure>
    <time_frame>up 120 minutes</time_frame>
    <description>time of CSE to time request of additional supplement analgesia in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of Analgesia</measure>
    <time_frame>up to 20 minutes</time_frame>
    <description>time to VAS&lt;/=3 on a 0-10 scale with 0=no pain up to 10= worst pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Highest Sensory Block</measure>
    <time_frame>up to 20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Had Occurrence of Fetal Bradycardia</measure>
    <time_frame>length of labor, up to 24 hours</time_frame>
    <description>occurrence of common side effects of spinal/epidural administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Had Occurrence of Maternal Hypotension</measure>
    <time_frame>length of labor, up to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Use of Vasopressors</measure>
    <time_frame>length of labor, up to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Had Occurrence of Itching</measure>
    <time_frame>length of labor, up to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Had Occurrence of Post Dural Puncture Headache</measure>
    <time_frame>length of labor, up to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time for 2 Dermatome Level Regression of Sensory Block</measure>
    <time_frame>up to 20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time for Regression of Motor Blockade</measure>
    <time_frame>up to 20 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>0 mls saline injected</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>NO SALINE INJECTED</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15 mls saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15ML SALINE ADMINISTERED EPIDURALLY</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sterile normal saline 0 mls</intervention_name>
    <description>at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
    <arm_group_label>0 mls saline injected</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>15 mls sterile normal saline</intervention_name>
    <description>After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
    <arm_group_label>15 mls saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age greater than 12 years of age

          -  ASA status 1 or 2

          -  cervical dilation &lt; 6cm

        Exclusion Criteria:

          -  ASA assigned 3 or 4

          -  advanced labor (&gt; 6cm cervical dilated)

          -  distorted epidural anatomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter H Pan, MD, MSEE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Forsyth Medical Center-Sara Lee Center for Women's Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>February 1, 2010</study_first_submitted>
  <study_first_submitted_qc>February 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2010</study_first_posted>
  <results_first_submitted>September 10, 2018</results_first_submitted>
  <results_first_submitted_qc>October 12, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 16, 2018</results_first_posted>
  <last_update_submitted>October 12, 2018</last_update_submitted>
  <last_update_submitted_qc>October 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>labor pain treatment</keyword>
  <keyword>duration analgesia</keyword>
  <keyword>Analgesic duration with normal saline injection.</keyword>
  <keyword>Analgesic duration without normal saline injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 25, 2011</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT01062893/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>0 Mls Saline Injected</title>
          <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
        </group>
        <group group_id="P2">
          <title>15 Mls Saline</title>
          <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>0 Mls Saline Injected</title>
          <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
        </group>
        <group group_id="B2">
          <title>15 Mls Saline</title>
          <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="55"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Highest Sensory Blockade Level to Pinprick and to Cold</title>
        <description>Onset of analgesia to recession of analgesia. Highest spread of analgesia (highest sensory level) to cold temp and pinprick, with level defined from T1 to L5, where T1 is highest =level 17 and L5 is lowest =Level 1)</description>
        <time_frame>up to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Highest Sensory Blockade Level to Pinprick and to Cold</title>
          <description>Onset of analgesia to recession of analgesia. Highest spread of analgesia (highest sensory level) to cold temp and pinprick, with level defined from T1 to L5, where T1 is highest =level 17 and L5 is lowest =Level 1)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="2.9"/>
                    <measurement group_id="O2" value="11.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Analgesia (Time to Request Additional Analgesia)</title>
        <description>time of CSE to time request of additional supplement analgesia in minutes</description>
        <time_frame>up 120 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Analgesia (Time to Request Additional Analgesia)</title>
          <description>time of CSE to time request of additional supplement analgesia in minutes</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.2" spread="33.9"/>
                    <measurement group_id="O2" value="77.3" spread="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Onset of Analgesia</title>
        <description>time to VAS&lt;/=3 on a 0-10 scale with 0=no pain up to 10= worst pain imaginable</description>
        <time_frame>up to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Onset of Analgesia</title>
          <description>time to VAS&lt;/=3 on a 0-10 scale with 0=no pain up to 10= worst pain imaginable</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.96" spread="5.24"/>
                    <measurement group_id="O2" value="6.07" spread="3.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Highest Sensory Block</title>
        <time_frame>up to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Highest Sensory Block</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.96" spread="8.69"/>
                    <measurement group_id="O2" value="13.57" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Had Occurrence of Fetal Bradycardia</title>
        <description>occurrence of common side effects of spinal/epidural administration</description>
        <time_frame>length of labor, up to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Occurrence of Fetal Bradycardia</title>
          <description>occurrence of common side effects of spinal/epidural administration</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Had Occurrence of Maternal Hypotension</title>
        <time_frame>length of labor, up to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Occurrence of Maternal Hypotension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Occurrence of Use of Vasopressors</title>
        <time_frame>length of labor, up to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Use of Vasopressors</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Had Occurrence of Itching</title>
        <time_frame>length of labor, up to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Occurrence of Itching</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Had Occurrence of Post Dural Puncture Headache</title>
        <time_frame>length of labor, up to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Occurrence of Post Dural Puncture Headache</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time for 2 Dermatome Level Regression of Sensory Block</title>
        <time_frame>up to 20 minutes</time_frame>
        <population>No data collected</population>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Time for 2 Dermatome Level Regression of Sensory Block</title>
          <population>No data collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time for Regression of Motor Blockade</title>
        <time_frame>up to 20 minutes</time_frame>
        <population>No data collected</population>
        <group_list>
          <group group_id="O1">
            <title>0 Mls Saline Injected</title>
            <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
          </group>
          <group group_id="O2">
            <title>15 Mls Saline</title>
            <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
          </group>
        </group_list>
        <measure>
          <title>Time for Regression of Motor Blockade</title>
          <population>No data collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>0 Mls Saline Injected</title>
          <description>NO SALINE INJECTED
Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.</description>
        </group>
        <group group_id="E2">
          <title>15 Mls Saline</title>
          <description>15ML SALINE ADMINISTERED EPIDURALLY
15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Peter H. Pan, MD</name_or_title>
      <organization>Wake Forest University School of Medicine</organization>
      <phone>336-718-8278</phone>
      <email>ppan@wakehealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

